Zacks Investment ResearchWed, 24 Jun 2026 14:55:29 GMTCan Veradermics (MANE) Climb 27.65% to Reach the Level Wall Street Analysts Expect?MANE+9.60%
Seeking AlphaMon, 08 Jun 2026 20:48:32 GMTVeradermics, Incorporated (MANE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Prepared Remarks TranscriptMANE+9.60%
Seeking AlphaTue, 28 Apr 2026 18:17:27 GMTVeradermics: Positive VDPHL01 Data Strengthens Late-Stage Pipeline ThesisMANE+9.60%
Seeking AlphaMon, 27 Apr 2026 19:51:32 GMTVeradermics, Incorporated (MANE) Discusses Positive Topline Results from Phase 2/3 Study of VDPHL01 for Mild-to-Moderate Pattern Hair Loss TranscriptMANE+9.60%
BenzingaMon, 27 Apr 2026 15:13:50 GMTNewly Listed Veradermics Hair Loss Drug Shows Hair Growth GainsMANE+9.60%
Investors Business DailyMon, 27 Apr 2026 13:26:47 GMTHow This Biotech, Up 25%, Is Taking A Page Out Of Rogaine's PlaybookMANE+9.60%